PubMed Aroda, V.R., Rosenstock, J., Terauchi, Y., Altuntas, Y., Lalic, N.M., Morales Villegas, E.C., et al
Two promising medications in this field are cagrilintide and tirzepatide
Dosing Protocols for Injury Recovery There is no FDA-approved dosing for BPC 157 and TB 500, but anecdotal use often follows patterns like: BPC 157: 200500 mcg daily, sometimes injected near the injury
The backdrop is unusual insofar as the FDA's own multidisciplinary scientific review team had recommended against all seven peptides, while essentially all of the yes votes for the six recommended peptides came from members recently appointed by Robert F
If BPC-157 is appropriate, we develop a personalized protocol, coordinate with your other providers if needed, and prescribe from a trusted compounding pharmacy